Indeed, we found a dose-dependent inhibition of the binding of biotinylated soluble MAdCAM-1 to RA-treated CD4+ T cells in 1mM MnCl2/100μM CaCl2 buffer (Mn++/Ca++ buffer; Fig 1A). Here, MADCAM1 is linked to rheumatoid arthritis.